{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:09:37Z","timestamp":1792804177400,"version":"4.5.0"},"reference-count":120,"publisher":"The Endocrine Society","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,9,1]]},"abstract":"<jats:p>Lymphangioleiomyomatosis (LAM) is a devastating rare lung disease affecting primarily childbearing age women in which tumors consisting of abnormal smooth-muscle-like cells grow within the lungs and progressively lead to loss of pulmonary function. LAM cells metastasize to the lungs, predominantly through the lymphatics; however, the source of the LAM cell is still unknown. LAM cells contain inactivating mutations in genes encoding tuberous sclerosis 1 or 2, proteins that normally limit cell growth through suppression of mammalian target of rapamycin complex 1. As of today, sirolimus (an mammalian target of rapamycin complex 1 inhibitor) is the only treatment, available for LAM patients that is approved by the Food and Drug Administration; however, this drug and others in its class provide stabilization but not remission of LAM. One of the biggest problems in treating LAM is that both the origin of the LAM cells and the mechanism of the sexual dimorphism in LAM are still not understood. LAM cells express estrogen and progesterone receptors, and lung function declines during periods of high circulating estrogen levels. Moreover, numerous basic research studies find that estrogen is a key driving force in LAM cell proliferation, migration, and metastasis. In this review, we highlight recent insights regarding the role of steroid hormones in LAM and discuss possible explanations for the profound female sexual dimorphism of LAM.<\/jats:p>","DOI":"10.1210\/en.2016-1395","type":"journal-article","created":{"date-parts":[[2016,7,13]],"date-time":"2016-07-13T17:08:01Z","timestamp":1468429681000},"page":"3374-3383","source":"Crossref","is-referenced-by-count":47,"title":["Minireview: Lymphangioleiomyomatosis (LAM): The \u201cOther\u201d Steroid-Sensitive Cancer"],"prefix":"10.1210","volume":"157","author":[{"given":"Hen","family":"Prizant","sequence":"first","affiliation":[{"name":"Departments of Medicine and Pharmacology, University of Rochester Medical Center, Rochester, New York 14642"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen R.","family":"Hammes","sequence":"first","affiliation":[{"name":"Departments of Medicine and Pharmacology, University of Rochester Medical Center, Rochester, New York 14642"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2016,7,13]]},"reference":[{"key":"2020071611551478200_B1","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1148\/rg.253055006","article-title":"From the archives of the AFIP: lymphangioleiomyomatosis: radiologic-pathologic correlation","volume":"25","author":"Abbott","year":"2005","journal-title":"Radiographics"},{"key":"2020071611551478200_B2","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1164\/ajrccm.151.2.7842216","article-title":"Pulmonary lymphangioleiomyomatosis: a report of 46 patients including a clinicopathologic study of prognostic factors","volume":"151","author":"Kitaichi","year":"1995","journal-title":"Am J Respir Crit Care Med"},{"key":"2020071611551478200_B3","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1164\/ajrccm.162.2.9911006","article-title":"Pulmonary lymphangioleiomyomatosis in a man","volume":"162","author":"Aubry","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"2020071611551478200_B4","first-page":"525","article-title":"Pulmonary lymphangioleiomyomatosis in a male patient with tuberous sclerosis complex","volume":"23","author":"Miyake","year":"2005","journal-title":"Radiat Med"},{"key":"2020071611551478200_B5","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/0020-7292(95)02619-3","article-title":"Pregnancy exacerbating unsuspected mediastinal lymphangioleiomyomatosis and chylothorax","volume":"52","author":"Brunelli","year":"1996","journal-title":"Int J Gynaecol Obstet"},{"key":"2020071611551478200_B6","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1378\/chest.91.5.782","article-title":"Exacerbation of pulmonary lymphangioleiomyomatosis by exogenous estrogens","volume":"91","author":"Shen","year":"1987","journal-title":"Chest"},{"key":"2020071611551478200_B7","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1136\/thorax.57.12.1085","article-title":"Exacerbation of pulmonary lymphangioleiomyomatosis by exogenous oestrogen used for infertility treatment","volume":"57","author":"Yano","year":"2002","journal-title":"Thorax"},{"key":"2020071611551478200_B8","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1164\/ajrccm.160.2.9901027","article-title":"Decline in lung function in lymphangioleiomyomatosis: relation to menopause and progesterone treatment","volume":"160","author":"Johnson","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"2020071611551478200_B9","doi-asserted-by":"crossref","first-page":"6085","DOI":"10.1073\/pnas.97.11.6085","article-title":"Mutations in the tuberous sclerosis complex gene TSC2 are a cause of sporadic pulmonary lymphangioleiomyomatosis","volume":"97","author":"Carsillo","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"2020071611551478200_B10","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1086\/301804","article-title":"Evidence that lymphangiomyomatosis is caused by TSC2 mutations: chromosome 16p13 loss of heterozygosity in angiomyolipomas and lymph nodes from women with lymphangiomyomatosis","volume":"62","author":"Smolarek","year":"1998","journal-title":"Am J Hum Genet"},{"key":"2020071611551478200_B11","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.molcel.2012.06.009","article-title":"TBC1D7 is a third subunit of the TSC1-TSC2 complex upstream of mTORC1","volume":"47","author":"Dibble","year":"2012","journal-title":"Mol Cell"},{"key":"2020071611551478200_B12","doi-asserted-by":"crossref","first-page":"R785","DOI":"10.1016\/S0960-9822(02)01294-0","article-title":"Growth signaling: TSC takes its place","volume":"12","author":"Marygold","year":"2002","journal-title":"Curr Biol"},{"key":"2020071611551478200_B13","doi-asserted-by":"crossref","first-page":"E214","DOI":"10.1038\/ncb0902-e214","article-title":"TSC1-TSC2: a complex tale of PKB-mediated S6K regulation","volume":"4","author":"McManus","year":"2002","journal-title":"Nat Cell Biol"},{"key":"2020071611551478200_B14","doi-asserted-by":"crossref","first-page":"E1647","DOI":"10.1152\/ajpendo.00674.2006","article-title":"The rapid activation of protein synthesis by growth hormone requires signaling through mTOR","volume":"292","author":"Hayashi","year":"2007","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2020071611551478200_B15","doi-asserted-by":"crossref","first-page":"30958","DOI":"10.1074\/jbc.M202678200","article-title":"Tuberin regulates p70 S6 kinase activation and ribosomal protein S6 phosphorylation. A role for the TSC2 tumor suppressor gene in pulmonary lymphangioleiomyomatosis (LAM)","volume":"277","author":"Goncharova","year":"2002","journal-title":"J Biol Chem"},{"key":"2020071611551478200_B16","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1378\/chest.12-2813","article-title":"Lymphangioleiomyomatosis screening in women with tuberous sclerosis","volume":"144","author":"Cudzilo","year":"2013","journal-title":"Chest"},{"key":"2020071611551478200_B17","doi-asserted-by":"crossref","first-page":"691","DOI":"10.2147\/TCRM.S50784","article-title":"Lymphangioleiomyomatosis: differential diagnosis and optimal management","volume":"10","author":"Xu","year":"2014","journal-title":"Ther Clin Risk Manag"},{"key":"2020071611551478200_B18","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1136\/jmg.37.1.55","article-title":"Mutational analysis of the tuberous sclerosis gene TSC2 in patients with pulmonary lymphangioleiomyomatosis","volume":"37","author":"Astrinidis","year":"2000","journal-title":"J Med Genet"},{"key":"2020071611551478200_B19","first-page":"106","article-title":"Lymphatic manifestations of lymphangioleiomyomatosis","volume":"47","author":"Gupta","year":"2014","journal-title":"Lymphology"},{"key":"2020071611551478200_B20","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1097\/PAS.0b013e318235edbd","article-title":"Prevalence of uterine and adnexal involvement in pulmonary lymphangioleiomyomatosis: a clinicopathologic study of 10 patients","volume":"35","author":"Hayashi","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"2020071611551478200_B21","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1053\/hupa.2000.18500","article-title":"Extrapulmonary lymphangioleiomyomatosis (LAM): clinicopathologic features in 22 cases","volume":"31","author":"Matsui","year":"2000","journal-title":"Hum Pathol"},{"key":"2020071611551478200_B22","doi-asserted-by":"crossref","first-page":"641","DOI":"10.4065\/70.7.641","article-title":"Extrapulmonary lymphangioleiomyomatosis and lymphangiomatous cysts in tuberous sclerosis complex","volume":"70","author":"Torres","year":"1995","journal-title":"Mayo Clin Proc"},{"key":"2020071611551478200_B23","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/0090-4295(93)90504-4","article-title":"Renal angiomyolipoma in association with pulmonary lymphangioleiomyomatosis: forme fruste of tuberous sclerosis?","volume":"41","author":"Kerr","year":"1993","journal-title":"Urology"},{"key":"2020071611551478200_B24","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/S0272-6386(03)00006-4","article-title":"Renal angiomyolipoma in association with pulmonary lymphangioleiomyomatosis","volume":"41","author":"De Pauw","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"2020071611551478200_B25","doi-asserted-by":"crossref","first-page":"e24919","DOI":"10.1371\/journal.pone.0024919","article-title":"Angiomyolipoma have common mutations in TSC2 but no other common genetic events","volume":"6","author":"Qin","year":"2011","journal-title":"PLoS One"},{"key":"2020071611551478200_B26","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1272\/jnms.67.311","article-title":"Lymphangioleiomyomatosis (LAM): a review of clinical and morphological features","volume":"67","author":"Ferrans","year":"2000","journal-title":"J Nihon Med Sch"},{"key":"2020071611551478200_B27","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1089\/lrb.2009.0020","article-title":"mTOR activation, lymphangiogenesis, and estrogen-mediated cell survival: the \u201cperfect storm\u201d of pro-metastatic factors in LAM pathogenesis","volume":"8","author":"Yu","year":"2010","journal-title":"Lymphat Res Biol"},{"key":"2020071611551478200_B28","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1164\/rccm.200208-969OC","article-title":"Recurrent lymphangiomyomatosis after transplantation: genetic analyses reveal a metastatic mechanism","volume":"167","author":"Karbowniczek","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"2020071611551478200_B29","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1053\/hupa.2003.50","article-title":"Recurrence of lymphangioleiomyomatosis after single lung transplantation: new insights into pathogenesis","volume":"34","author":"Bittmann","year":"2003","journal-title":"Hum Pathol"},{"key":"2020071611551478200_B30","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1164\/rccm.201412-2170LE","article-title":"Genetic heterogeneity of circulating cells from patients with lymphangioleiomyomatosis with and without lung transplantation","volume":"191","author":"Steagall","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"2020071611551478200_B31","doi-asserted-by":"crossref","first-page":"17462","DOI":"10.1073\/pnas.0407971101","article-title":"Molecular and genetic analysis of disseminated neoplastic cells in lymphangioleiomyomatosis","volume":"101","author":"Crooks","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"2020071611551478200_B32","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1096\/fasebj.5.8.1850705","article-title":"Matrix metalloproteinases and their inhibitors in connective tissue remodeling","volume":"5","author":"Woessner","year":"1991","journal-title":"FASEB J"},{"key":"2020071611551478200_B33","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1016\/j.bmc.2007.01.011","article-title":"Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs","volume":"15","author":"Verma","year":"2007","journal-title":"Bioorg Med Chem"},{"key":"2020071611551478200_B34","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1465-9921-13-34","article-title":"Clinical utility of diagnostic guidelines and putative biomarkers in lymphangioleiomyomatosis","volume":"13","author":"Chang","year":"2012","journal-title":"Respir Res"},{"key":"2020071611551478200_B35","doi-asserted-by":"crossref","first-page":"267","DOI":"10.5858\/2000-124-0267-RFAOMM","article-title":"Role for activation of matrix metalloproteinases in the pathogenesis of pulmonary lymphangioleiomyomatosis","volume":"124","author":"Matsui","year":"2000","journal-title":"Arch Pathol Lab Med"},{"key":"2020071611551478200_B36","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/S0046-8177(97)90061-7","article-title":"Immunohistochemical study of matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in pulmonary lymphangioleiomyomatosis (LAM)","volume":"28","author":"Hayashi","year":"1997","journal-title":"Hum Pathol"},{"key":"2020071611551478200_B37","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1210\/jc.2007-1283","article-title":"Activation of the estrogen receptor contributes to the progression of pulmonary lymphangioleiomyomatosis via matrix metalloproteinase-induced cell invasiveness","volume":"93","author":"Glassberg","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071611551478200_B38","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.rmed.2008.07.017","article-title":"Matrix metalloproteinases in blood from patients with LAM","volume":"103","author":"Odajima","year":"2009","journal-title":"Respir Med"},{"key":"2020071611551478200_B39","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1590\/S1806-37132011000400003","article-title":"Doxycycline use in patients with lymphangioleiomyomatosis: safety and efficacy in metalloproteinase blockade","volume":"37","author":"Pimenta","year":"2011","journal-title":"J Bras Pneumol"},{"key":"2020071611551478200_B40","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1158\/0008-5472.CAN-13-1256","article-title":"SRC kinase is a novel therapeutic target in lymphangioleiomyomatosis","volume":"74","author":"Tyryshkin","year":"2014","journal-title":"Cancer Res"},{"key":"2020071611551478200_B41","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1177\/10454411910020030201","article-title":"Tetracyclines inhibit connective tissue breakdown: new therapeutic implications for an old family of drugs","volume":"2","author":"Golub","year":"1991","journal-title":"Crit Rev Oral Biol Med"},{"key":"2020071611551478200_B42","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1476-5381.2011.01344.x","article-title":"Doxycycline inhibits matrix metalloproteinase-2 secretion from TSC2-null mouse embryonic fibroblasts and lymphangioleiomyomatosis cells","volume":"164","author":"Moir","year":"2011","journal-title":"Br J Pharmacol"},{"key":"2020071611551478200_B43","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1111\/jcmm.12593","article-title":"Doxycycline reduces the migration of tuberous sclerosis complex-2 null cells - effects on RhoA-GTPase and focal adhesion kinase","volume":"19","author":"Ng","year":"2015","journal-title":"J Cell Mol Med"},{"key":"2020071611551478200_B44","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1056\/NEJMc053410","article-title":"Doxycycline treatment for lymphangioleiomyomatosis with urinary monitoring for MMPs","volume":"354","author":"Moses","year":"2006","journal-title":"N Engl J Med"},{"key":"2020071611551478200_B45","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1590\/S1806-37132013000100002","article-title":"Doxycycline use in patients with lymphangioleiomyomatosis: biomarkers and pulmonary function response","volume":"39","author":"Pimenta","year":"2013","journal-title":"J Bras Pneumol"},{"key":"2020071611551478200_B46","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1183\/09031936.00167413","article-title":"A 2-year randomised placebo-controlled trial of doxycycline for lymphangioleiomyomatosis","volume":"43","author":"Chang","year":"2014","journal-title":"Eur Respir J"},{"key":"2020071611551478200_B47","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1359\/jbmr.2003.18.2.222","article-title":"Cathepsin K mRNA and protein expression in prostate cancer progression","volume":"18","author":"Brubaker","year":"2003","journal-title":"J Bone Miner Res"},{"key":"2020071611551478200_B48","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.suronc.2007.01.003","article-title":"Neutrophil elastase and cancer","volume":"15","author":"Sato","year":"2006","journal-title":"Surg Oncol"},{"key":"2020071611551478200_B49","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/modpathol.2008.189","article-title":"Cathepsin-k expression in pulmonary lymphangioleiomyomatosis","volume":"22","author":"Chilosi","year":"2009","journal-title":"Mod Pathol"},{"key":"2020071611551478200_B50","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/01.moh.0000190113.31027.d5","article-title":"Neutrophil granule contents in the pathogenesis of lung injury","volume":"13","author":"Moraes","year":"2006","journal-title":"Curr Opin Hematol"},{"key":"2020071611551478200_B51","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1089\/jam.2004.17.289","article-title":"Potential role of inhibitors of neutrophil elastase in treating diseases of the airway","volume":"17","author":"Chughtai","year":"2004","journal-title":"J Aerosol Med"},{"key":"2020071611551478200_B52","doi-asserted-by":"crossref","first-page":"16000","DOI":"10.1073\/pnas.1507294112","article-title":"Lung inflammation promotes metastasis through neutrophil protease-mediated degradation of Tsp-1","volume":"112","author":"El Rayes","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"key":"2020071611551478200_B53","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1530\/ERC-15-0505","article-title":"Estrogen maintains myometrial tumors in a lymphangioleiomyomatosis model","volume":"23","author":"Prizant","year":"2016","journal-title":"Endocr Relat Cancer"},{"key":"2020071611551478200_B54","first-page":"6","article-title":"Lymphangioleiomyomatosis: clinical course","volume":"49","author":"Schiavina","year":"1994","journal-title":"Monaldi Arch Chest Dis"},{"key":"2020071611551478200_B55","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1164\/rccm.200610-1408CR","article-title":"Pulmonary lymphangioleiomyomatosis in a karyotypically normal man without tuberous sclerosis complex","volume":"176","author":"Schiavina","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"2020071611551478200_B56","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1093\/ajcp\/93.5.609","article-title":"Pulmonary lymphangioleiomyomatosis and steroid receptors. An immunocytochemical study","volume":"93","author":"Berger","year":"1990","journal-title":"Am J Clin Pathol"},{"key":"2020071611551478200_B57","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2739\/kurumemedj.42.141","article-title":"Hormone receptors in pulmonary lymphangiomyomatosis","volume":"42","author":"Kinoshita","year":"1995","journal-title":"Kurume Med J"},{"key":"2020071611551478200_B58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5603\/FHC.2013.001","article-title":"LAM cells biology and lymphangioleiomyomatosis","volume":"51","author":"Grzegorek","year":"2013","journal-title":"Folia Histochem Cytobiol"},{"key":"2020071611551478200_B59","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/00005792-199909000-00004","article-title":"Pulmonary lymphangioleiomyomatosis. A study of 69 patients. Groupe d'Etudes et de Recherche sur les Maladies \u201cOrphelines\u201d Pulmonaires (GERM\u201cO\u201dP)","volume":"78","author":"Urban","year":"1999","journal-title":"Medicine (Baltimore)"},{"key":"2020071611551478200_B60","doi-asserted-by":"crossref","first-page":"4277","DOI":"10.1242\/dev.127.19.4277","article-title":"Effect of single and compound knockouts of estrogen receptors \u03b1 (ER\u03b1) and \u03b2 (ER\u03b2) on mouse reproductive phenotypes","volume":"127","author":"Dupont","year":"2000","journal-title":"Development"},{"key":"2020071611551478200_B61","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1159\/000055275","article-title":"Molecular bases for the actions of ovarian sex steroids in the regulation of proliferation and apoptosis of human uterine leiomyoma","volume":"57","author":"Matsuo","year":"1999","journal-title":"Oncology"},{"key":"2020071611551478200_B62","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1159\/000226658","article-title":"Receptors for epidermal growth factor and steroid hormones in human breast cancer","volume":"45","author":"Battaglia","year":"1988","journal-title":"Oncology"},{"key":"2020071611551478200_B63","first-page":"6517","article-title":"Stimulation of c-myc oncogene expression associated with estrogen-induced proliferation of human breast cancer cells","volume":"47","author":"Dubik","year":"1987","journal-title":"Cancer Res"},{"key":"2020071611551478200_B64","doi-asserted-by":"crossref","first-page":"L694","DOI":"10.1152\/ajplung.00204.2003","article-title":"Estradiol and tamoxifen stimulate LAM-associated angiomyolipoma cell growth and activate both genomic and nongenomic signaling pathways","volume":"286","author":"Yu","year":"2004","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"2020071611551478200_B65","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1165\/rcmb.2012-0476OC","article-title":"Faslodex inhibits estradiol-induced extracellular matrix dynamics and lung metastasis in a model of lymphangioleiomyomatosis","volume":"49","author":"Li","year":"2013","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2020071611551478200_B66","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1084\/jem.20131080","article-title":"Estradiol and mTORC2 cooperate to enhance prostaglandin biosynthesis and tumorigenesis in TSC2-deficient LAM cells","volume":"211","author":"Li","year":"2014","journal-title":"J Exp Med"},{"key":"2020071611551478200_B67","doi-asserted-by":"crossref","first-page":"14960","DOI":"10.1073\/pnas.1309110110","article-title":"Integration of mTOR and estrogen-ERK2 signaling in lymphangioleiomyomatosis pathogenesis","volume":"110","author":"Gu","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"2020071611551478200_B68","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1073\/pnas.0810790106","article-title":"Estrogen promotes the survival and pulmonary metastasis of tuberin-null cells","volume":"106","author":"Yu","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"2020071611551478200_B69","doi-asserted-by":"crossref","first-page":"e1231","DOI":"10.1038\/cddis.2014.204","article-title":"Estradiol promotes pentose phosphate pathway addiction and cell survival via reactivation of Akt in mTORC1 hyperactive cells","volume":"5","author":"Sun","year":"2014","journal-title":"Cell Death Dis"},{"key":"2020071611551478200_B70","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1677\/ERC-08-0123","article-title":"Analysis of the oestrogen response in an angiomyolipoma derived xenograft model","volume":"16","author":"Clements","year":"2009","journal-title":"Endocr Relat Cancer"},{"key":"2020071611551478200_B71","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1210\/me.2013-1059","article-title":"Uterine-specific loss of Tsc2 leads to myometrial tumors in both the uterus and lungs","volume":"27","author":"Prizant","year":"2013","journal-title":"Mol Endocrinol"},{"key":"2020071611551478200_B72","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1369\/jhc.4A6438.2004","article-title":"Combined smooth muscle and melanocytic differentiation in lymphangioleiomyomatosis","volume":"52","author":"Zhe","year":"2004","journal-title":"J Histochem Cytochem"},{"key":"2020071611551478200_B73","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1183\/09031936.95.08111879","article-title":"Diagnosis of pulmonary lymphangioleiomyomatosis by HMB45 in surgically treated spontaneous pneumothorax","volume":"8","author":"Tanaka","year":"1995","journal-title":"Eur Respir J"},{"key":"2020071611551478200_B74","doi-asserted-by":"crossref","first-page":"33","DOI":"10.5858\/2008-0542-RAR1.1","article-title":"Molecular pathology of lymphangioleiomyomatosis and other perivascular epithelioid cell tumors","volume":"134","author":"Martignoni","year":"2010","journal-title":"Arch Pathol Lab Med"},{"key":"2020071611551478200_B75","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/nature03664","article-title":"Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma","volume":"436","author":"Garraway","year":"2005","journal-title":"Nature"},{"key":"2020071611551478200_B76","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0002-9440(10)63657-7","article-title":"MLANA\/MART1 and SILV\/PMEL17\/GP100 are transcriptionally regulated by MITF in melanocytes and melanoma","volume":"163","author":"Du","year":"2003","journal-title":"Am J Pathol"},{"key":"2020071611551478200_B77","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.molmed.2006.07.008","article-title":"MITF: master regulator of melanocyte development and melanoma oncogene","volume":"12","author":"Levy","year":"2006","journal-title":"Trends Mol Med"},{"key":"2020071611551478200_B78","first-page":"699","article-title":"Comparison of melanoma antigen recognized by T cells (MART-1) to HMB-45: additional evidence to support a common lineage for angiomyolipoma, lymphangiomyomatosis, and clear cell sugar tumor","volume":"11","author":"Fetsch","year":"1998","journal-title":"Mod Pathol"},{"key":"2020071611551478200_B79","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.2353\/ajpath.2009.090525","article-title":"Melanoma-associated antigen expression in lymphangioleiomyomatosis renders tumor cells susceptible to cytotoxic T cells","volume":"175","author":"Klarquist","year":"2009","journal-title":"Am J Pathol"},{"key":"2020071611551478200_B80","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1755-148X.2008.00518.x","article-title":"Gpnmb is a melanoblast-expressed, MITF-dependent gene","volume":"22","author":"Loftus","year":"2009","journal-title":"Pigment Cell Melanoma Res"},{"key":"2020071611551478200_B81","doi-asserted-by":"crossref","first-page":"e12093","DOI":"10.1371\/journal.pone.0012093","article-title":"ADAM10 releases a soluble form of the GPNMB\/osteoactivin extracellular domain with angiogenic properties","volume":"5","author":"Rose","year":"2010","journal-title":"PLoS One"},{"key":"2020071611551478200_B82","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1158\/1078-0432.CCR-05-2018","article-title":"CR011, a fully human monoclonal antibody-auristatin E conjugate, for the treatment of melanoma","volume":"12","author":"Tse","year":"2006","journal-title":"Clin Cancer Res"},{"key":"2020071611551478200_B83","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.yexcr.2014.02.025","article-title":"GPNMB\/OA protein increases the invasiveness of human metastatic prostate cancer cell lines DU145 and PC3 through MMP-2 and MMP-9 activity","volume":"323","author":"Fiorentini","year":"2014","journal-title":"Exp Cell Res"},{"key":"2020071611551478200_B84","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1056\/NEJM198107233050406","article-title":"Efficacy of oophorectomy in lymphangioleiomyomatosis and benign metastasizing leiomyoma","volume":"305","author":"Banner","year":"1981","journal-title":"N Engl J Med"},{"key":"2020071611551478200_B85","first-page":"39","article-title":"Efficacy of hormonal manipulation in lymphangioleiomyomatosis. A 20-year-experience in 36 patients","volume":"24","author":"Schiavina","year":"2007","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"2020071611551478200_B86","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1164\/ajrccm\/143.1.174","article-title":"Response to treatment with an analog of the luteinizing-hormone-releasing hormone in a patient with pulmonary lymphangioleiomyomatosis","volume":"143","author":"Rossi","year":"1991","journal-title":"Am Rev Respir Dis"},{"key":"2020071611551478200_B87","first-page":"246","article-title":"Successful treatment of pulmonary lymphangioleiomyomatosis with oophorectomy and medroxyprogesterone-acetate: report of a case and brief review of the literature","volume":"36","author":"van Milligen de Wit","year":"1990","journal-title":"Neth J Med"},{"key":"2020071611551478200_B88","first-page":"403","article-title":"Sex steroid hormones and circulating IgE levels","volume":"30","author":"Mathur","year":"1977","journal-title":"Clin Exp Immunol"},{"key":"2020071611551478200_B89","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s00428-014-1559-9","article-title":"In pulmonary lymphangioleiomyomatosis expression of progesterone receptor is frequently higher than that of estrogen receptor","volume":"464","author":"Gao","year":"2014","journal-title":"Virchows Arch"},{"key":"2020071611551478200_B90","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1007\/s12672-014-0192-z","article-title":"Progesterone and estradiol synergistically promote the lung metastasis of tuberin-deficient cells in a preclinical model of lymphangioleiomyomatosis","volume":"5","author":"Sun","year":"2014","journal-title":"Horm Cancer"},{"key":"2020071611551478200_B91","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.steroids.2009.07.011","article-title":"Estrogen-induced stromal cell-derived factor-1 (SDF-1\/Cxcl12) expression is repressed by progesterone and by selective estrogen receptor modulators via estrogen receptor \u03b1 in rat uterine cells and tissues","volume":"74","author":"Glace","year":"2009","journal-title":"Steroids"},{"key":"2020071611551478200_B92","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0303-7207(02)00230-7","article-title":"Transdominant suppression of estrogen receptor signaling by progesterone receptor ligands in uterine leiomyoma cells","volume":"196","author":"Hodges","year":"2002","journal-title":"Mol Cell Endocrinol"},{"key":"2020071611551478200_B93","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/0007-0971(85)90077-4","article-title":"A report of two long-surviving cases of pulmonary lymphangioleiomyomatosis and the response to progesterone therapy","volume":"79","author":"Sawicka","year":"1985","journal-title":"Br J Dis Chest"},{"key":"2020071611551478200_B94","first-page":"258","article-title":"Lymphangioleiomyomatosis\u2013treatment with progesterone","volume":"32","author":"Poh","year":"1991","journal-title":"Singapore Med J"},{"key":"2020071611551478200_B95","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1378\/chest.126.6.1867","article-title":"Decline in lung function in patients with lymphangioleiomyomatosis treated with or without progesterone","volume":"126","author":"Taveira-DaSilva","year":"2004","journal-title":"Chest"},{"key":"2020071611551478200_B96","first-page":"3090","article-title":"Estrogen receptor activation via activation function 2 predicts agonism of xenoestrogens in normal and neoplastic cells of the uterine myometrium","volume":"59","author":"Hunter","year":"1999","journal-title":"Cancer Res"},{"key":"2020071611551478200_B97","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.steroids.2014.06.008","article-title":"Nuclear receptor modulation\u2013role of coregulators in selective estrogen receptor modulator (SERM) actions","volume":"90","author":"Feng","year":"2014","journal-title":"Steroids"},{"key":"2020071611551478200_B98","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1097\/01.SMJ.0000051146.93190.4A","article-title":"Selective estrogen receptor modulators","volume":"96","author":"Haskell","year":"2003","journal-title":"South Med J"},{"key":"2020071611551478200_B99","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/j.addr.2010.08.001","article-title":"Selectively targeting estrogen receptors for cancer treatment","volume":"62","author":"Shanle","year":"2010","journal-title":"Adv Drug Deliv Rev"},{"key":"2020071611551478200_B100","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S1028-4559(08)60051-0","article-title":"The role of selective estrogen receptor modulators on breast cancer: from tamoxifen to raloxifene","volume":"47","author":"Lee","year":"2008","journal-title":"Taiwan J Obstet Gynecol"},{"key":"2020071611551478200_B101","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/S0140-6736(05)66544-0","article-title":"Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials","volume":"365","author":"Early Breast Cancer Trialists' Collaborative","year":"2005","journal-title":"Lancet"},{"key":"2020071611551478200_B102","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1124\/jpet.110.173955","article-title":"Tamoxifen regulation of bone growth and endocrine function in the ovariectomized rat: discrimination of responses involving estrogen receptor \u03b1\/estrogen receptor \u03b2, G protein-coupled estrogen receptor, or estrogen-related receptor \u03b3 using fulvestrant (ICI 182780)","volume":"338","author":"Fitts","year":"2011","journal-title":"J Pharmacol Exp Ther"},{"key":"2020071611551478200_B103","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1210\/en.2004-1114","article-title":"Tamoxifen stimulates cancellous bone formation in long bones of female mice","volume":"146","author":"Perry","year":"2005","journal-title":"Endocrinology"},{"key":"2020071611551478200_B104","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jsbmb.2008.03.021","article-title":"Signaling by estrogens and tamoxifen in the human endometrium","volume":"109","author":"Gielen","year":"2008","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2020071611551478200_B105","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.3892\/ol.2015.2962","article-title":"Molecular mechanisms of tamoxifen-associated endometrial cancer (review)","volume":"9","author":"Hu","year":"2015","journal-title":"Oncol Lett"},{"key":"2020071611551478200_B106","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/j.1749-6632.2001.tb03991.x","article-title":"An in vivo\/in vitro model to assess endocrine disrupting activity of xenoestrogens in uterine leiomyoma","volume":"948","author":"Hodges","year":"2001","journal-title":"Ann NY Acad Sci"},{"key":"2020071611551478200_B107","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1056\/NEJM199011013231807","article-title":"Lymphangioleiomyomatosis. Clinical course in 32 patients","volume":"323","author":"Taylor","year":"1990","journal-title":"N Engl J Med"},{"key":"2020071611551478200_B108","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/0007-0971(84)90139-6","article-title":"Pulmonary lymphangioleiomyomatosis: a case of progesterone receptor positive lymphangioleiomyomatosis treated with medroxyprogesterone, oophorectomy and tamoxifen","volume":"78","author":"Svendsen","year":"1984","journal-title":"Br J Dis Chest"},{"key":"2020071611551478200_B109","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.2174\/1381612043383926","article-title":"Regulation of myometrial smooth muscle functions","volume":"10","author":"Hertelendy","year":"2004","journal-title":"Curr Pharm Des"},{"key":"2020071611551478200_B110","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1093\/humupd\/dmh019","article-title":"Sex steroidal regulation of uterine leiomyoma growth and apoptosis","volume":"10","author":"Maruo","year":"2004","journal-title":"Hum Reprod Update"},{"key":"2020071611551478200_B111","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.fertnstert.2007.01.093","article-title":"Etiology, symptomatology, and diagnosis of uterine myomas","volume":"87","author":"Parker","year":"2007","journal-title":"Fertil Steril"},{"key":"2020071611551478200_B112","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1097\/00003081-200106000-00022","article-title":"Clinical symptomatology of uterine leiomyomas","volume":"44","author":"Stovall","year":"2001","journal-title":"Clin Obstet Gynecol"},{"key":"2020071611551478200_B113","first-page":"550","article-title":"[Pulmonary benign metastasizing leiomyoma: a clinicopathological study of 5 cases]","volume":"17","author":"Feng","year":"2014","journal-title":"Zhongguo Fei Ai Za Zhi"},{"key":"2020071611551478200_B114","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s00404-008-0698-0","article-title":"A case of benign metastasizing leiomyoma treated by surgical castration followed by an aromatase inhibitor, anastrozole","volume":"279","author":"Nasu","year":"2009","journal-title":"Arch Gynecol Obstet"},{"key":"2020071611551478200_B115","doi-asserted-by":"crossref","first-page":"960","DOI":"10.5858\/1999-123-0960-BMLOTU","article-title":"Benign metastasizing leiomyoma of the uterus: histologic and immunohistochemical characterization of primary and metastatic lesions","volume":"123","author":"Esteban","year":"1999","journal-title":"Arch Pathol Lab Med"},{"key":"2020071611551478200_B116","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/00000478-197908000-00004","article-title":"Pulmonary metastases (with admixed epithelial elements) from smooth muscle neoplasms. Report of nine cases, including three males","volume":"3","author":"Wolff","year":"1979","journal-title":"Am J Surg Pathol"},{"key":"2020071611551478200_B117","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.ccm.2004.01.014","article-title":"Benign metastasizing leiomyoma and lymphangioleiomyomatosis: sex-specific diseases?","volume":"25","author":"Pitts","year":"2004","journal-title":"Clin Chest Med"},{"key":"2020071611551478200_B118","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.fertnstert.2011.06.038","article-title":"Prevalence of uterine leiomyomas in lymphangioleiomyomatosis","volume":"96","author":"Taveira-Dasilva","year":"2011","journal-title":"Fertil Steril"},{"key":"2020071611551478200_B119","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1097\/00004347-199510000-00010","article-title":"Lymphangiomyomatosis of the uterus associated with tuberous sclerosis and malignant neoplasia of the female genital tract: a report of two cases","volume":"14","author":"Gyure","year":"1995","journal-title":"Int J Gynecol Pathol"},{"key":"2020071611551478200_B120","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/gcc.10281","article-title":"Uterine leiomyoma in the Eker rat: a unique model for important diseases of women","volume":"38","author":"Walker","year":"2003","journal-title":"Genes Chromosomes Cancer"}],"container-title":["Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/endo\/article-pdf\/157\/9\/3374\/10828966\/endo3374.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/endo\/article-pdf\/157\/9\/3374\/10828966\/endo3374.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,2]],"date-time":"2022-07-02T22:05:48Z","timestamp":1656799548000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/endo\/article\/157\/9\/3374\/2422360"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,13]]},"references-count":120,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2016,9,1]]}},"URL":"https:\/\/doi.org\/10.1210\/en.2016-1395","relation":{},"ISSN":["0013-7227","1945-7170"],"issn-type":[{"value":"0013-7227","type":"print"},{"value":"1945-7170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,13]]}}}